OTC · Medical - Devices

Nova Eye Medical Limited (ELXMF) Stock

$0.01 +0.00% OTC: ELXMF Healthcare

Headquartered in Kent Town, Australia, and established in 1985, Nova Eye Medical Limited is dedicated to the development, manufacturing, and global commercialization of surgical solutions for eye conditions, with a primary focus on glaucoma. Their product lineup features the iTrack surgical system, engineered to reduce intraocular pressure in adult patients with open-angle glaucoma, alongside its evolution, iTrack Advance, which promotes natural ocular fluid drainage.

Valuation

MetricValue
Price$0.01
Market Cap$4.08M
P/E Ratio-4.69
P/B Ratio2.16
P/S Ratio1.03
EPS (TTM)$-0.04
52-Week High$0.10
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-40.41%
ROA-29.70%
ROCE-29.00%
Gross Margin66.71%
Operating Margin-15.77%
Net Margin-21.27%
Debt/Equity0.31
Current Ratio1.85

Annual Financials (USD)

Metric20212022202320242025
Revenue$13.0M$13.0M$17.0M$23.0M$29.0M
Operating Profit$-5.0M$-7.0M$-12.0M$-9.0M$-5.0M
Net Profit$-4.0M$-7.0M$-15.0M$-9.0M$-9.0M
EPS$-0.03$-0.05$-0.10$-0.04$-0.04
Op Margin-37.1%-49.2%-69.6%-38.5%-15.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$42.0M$37.0M$30.0M$30.0M$27.0M
Total Liabilities$7.0M$6.0M$7.0M$9.0M$8.0M
Cash$18.0M$8.0M$7.0M$6.0M$5.0M
Borrowings$4.0M$2.0M$2.0M$3.0M$3.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-13.0M$-5.0M$-7.0M$-8.0M$-6.0M
Investing Cash Flow$-7.0M$-17.0M$-2.0M$-1.0M$-1.0M
Financing Cash Flow$-42.0M$0$0$0$6.0M
Net Cash Flow$-78.0M$-10.0M$-1.0M$-1.0M$-1.0M
Free Cash Flow$-15.0M$-10.0M$-8.0M$-8.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.14
EV / EBITDA-9.35
FCF Yield-15.19%
Quick Ratio1.24
Interest Coverage-28.32
Return 1Y-85.69%
Return 3Y-85.69%
Return 5Y-92.66%

Ownership

Insiders Held18.03%
Institutions Held18.18%
Institutions Float Held22.18%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AHGIFAlternate Health Corp. $0.00 — 0.00 $7788 0.00%
EOFBFEcofibre Ltd. $0.00 — -0.17 $378874 0.00%
IPDQFImpediMed Limited $0.00 — -0.37 $6.91M 0.00%
NVYTFNovacyt S.A. $0.48 +0.00% -0.80 $34.80M 0.00%
NXSCFNext Science Limited $0.00 — -0.03 $292625 0.00%

About Nova Eye Medical Limited

Headquartered in Kent Town, Australia, and established in 1985, Nova Eye Medical Limited is dedicated to the development, manufacturing, and global commercialization of surgical solutions for eye conditions, with a primary focus on glaucoma. Their product lineup features the iTrack surgical system, engineered to reduce intraocular pressure in adult patients with open-angle glaucoma, alongside its evolution, iTrack Advance, which promotes natural ocular fluid drainage. For individuals with severe or intricate forms of glaucoma, they provide the Molteno3 drainage device. Additionally, the company offers 2RT, a unique laser technology aimed at treating early to intermediate age-related macular degeneration. Nova Eye Medical Limited maintains a significant international footprint, conducting operations across Australia, the United States, Europe, and the Asia Pacific region. The company officially adopted its current name in July 2020, having previously operated as Ellex Medical Lasers Limited.

Nova Eye Medical Limited is headquartered in AU.

Nova Eye Medical Limited (ELXMF) stock trades at $0.01 with a market capitalization of $4.08M. The stock is valued at a price-to-earnings (P/E) ratio of -4.69, price-to-book of 2.16, price-to-sales of 1.03. Over the past 52 weeks the stock has ranged between $0.00 and $0.10, and currently trades 90.0% below its 52-week high.

On profitability, Nova Eye Medical Limited generates a return on equity (ROE) of -40.41%, return on capital employed of -29.00%, an operating margin of -15.77%, a net profit margin of -21.27%.

Official website: nova-eye.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides